Search Results - "Watkins, Elyse A."
-
1
Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin‐10 in Murine Models
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-05-2021)“…Objective Rheumatoid arthritis (RA) is a major autoimmune disease that causes synovitis and joint damage. Although clinical trials have been performed using…”
Get full text
Journal Article -
2
Soluble N-Acetylgalactosamine-Modified Antigens Enhance Hepatocyte-Dependent Antigen Cross-Presentation and Result in Antigen-Specific CD8 + T Cell Tolerance Development
Published in Frontiers in immunology (03-03-2021)“…Hepatocytes compose up to 80% of the total liver and have been indicated as important players in the induction of immunologic tolerance in this organ. We show…”
Get full text
Journal Article -
3
Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance
Published in Frontiers in immunology (24-09-2021)“…Inverse vaccines that tolerogenically target antigens to antigen-presenting cells (APCs) offer promise in prevention of immunity to allergens and protein drugs…”
Get full text
Journal Article -
4
BACE Inhibitor Clinical Trials for Alzheimer's Disease
Published in Journal of Alzheimer's disease (2024)“…The amyloid hypothesis posits that the amyloid-β aggregates in the brain initiate a cascade of events that eventually lead to neuron loss and Alzheimer's…”
Get more information
Journal Article -
5
Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
Published in Biomaterials (01-11-2021)“…The SARS-CoV-2 virus has caused an unprecedented global crisis, and curtailing its spread requires an effective vaccine which elicits a diverse and robust…”
Get full text
Journal Article -
6
Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B‑Cell Lymphoma
Published in ACS nano (12-12-2023)“…Diffuse large B-cell lymphoma (DLBCL) remains a formidable diagnosis in need of new treatment paradigms. In this work, we elucidated an opportunity for…”
Get full text
Journal Article -
7
Engineered bridge protein with dual affinity for bone morphogenetic protein-2 and collagen enhances bone regeneration for spinal fusion
Published in Science advances (01-06-2021)“…The revolutionizing efficacy of recombinant human bone morphogenetic protein (rhBMP-2) for clinical spinal fusion is hindered by safety issues associated with…”
Get full text
Journal Article -
8
Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics
Published in Cell reports. Medicine (16-01-2024)“…Immunogenic biologics trigger an anti-drug antibody (ADA) response in patients that reduces efficacy and increases adverse reactions. Our laboratory has shown…”
Get full text
Journal Article -
9
Mannose-Decorated Co-Polymer Facilitates Controlled Release of Butyrate to Accelerate Chronic Wound Healing
Published in Advanced healthcare materials (01-10-2023)“…Butyrate is a key bacterial metabolite that plays an important and complex role in modulation of immunity and maintenance of epithelial barriers. Its…”
Get full text
Journal Article -
10
Designing biofunctional immunotherapies
Published in Nature reviews. Materials (01-06-2019)“…Intelligent design of materials for biomedical applications involves the development of technologies that are informed by an understanding of biological…”
Get full text
Journal Article -
11
Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses
Published in Nature biomedical engineering (01-09-2023)“…Inducing antigen-specific tolerance during an established immune response typically requires non-specific immunosuppressive signalling molecules. Hence,…”
Get full text
Journal Article -
12
Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis
Published in Nature biomedical engineering (01-05-2021)“…Interleukin-4 (IL-4) suppresses the development of multiple sclerosis in a murine model of experimental autoimmune encephalomyelitis (EAE). Here, we show that,…”
Get full text
Journal Article -
13
A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice
Published in Nature biomedical engineering (01-05-2024)“…Butyrate—a metabolite produced by commensal bacteria—has been extensively studied for its immunomodulatory effects on immune cells, including regulatory T…”
Get full text
Journal Article -
14
Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction
Published in Science immunology (26-02-2021)“…Although most current treatments for autoimmunity involve broad immunosuppression, recent efforts have aimed to suppress T cells in an antigen-specific manner…”
Get more information
Journal Article -
15
Polymersomes Decorated with the SARS-CoV‑2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity
Published in ACS central science (25-08-2021)“…The COVID-19 pandemic underscores the need for rapid, safe, and effective vaccines. In contrast to some traditional vaccines, nanoparticle-based subunit…”
Get full text
Journal Article -
16
Publisher Correction: Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis
Published in Nature biomedical engineering (01-11-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
17
Adipose stem cell microbeads as production sources for chondrogenic growth factors
Published in Journal of stem cells & regenerative medicine (01-01-2014)“…Microencapsulating stem cells in injectable microbeads can enhance delivery and localization, but their ability to act as growth factor production sources is…”
Get full text
Journal Article -
18
Antigen targeted to the apoptotic pathway via dying erythrocytes leads to profound T cell exhaustion and tolerance
Published in The Journal of immunology (1950) (01-05-2020)“…Abstract The current standard of care for autoimmune disease is administration of immunosuppressive agents that require a lifetime of treatment and leave…”
Get full text
Journal Article